US Analyzes Third Dose At Risk Population, Lobby WHO To Boost Coronavirus Vaccination

From the United States Centers for Disease Control and Prevention (CDC, for its acronym in English) they continue to study the vaccine efficacy against the coronavirus and the health impact these have had in those who have obtained a full vaccination. The objective is determine if at-risk groups should receive a third dose.

Studies have focused on the population over 65 years of age and in immunocompromised patients. Despite a few weeks ago, the Food and Drug Administration (FDA) and CDC noted that it was not necessary to apply a new dose, the position could change in the coming days.

// CABA has received the first data on the coronavirus vaccine combination and is preparing to apply AstraZeneca and Sinopharm to those who already have Sputnik V

Amanda Cohn, medical director of the CDC’s immunization division, told an agency advisory committee that officials are “actively looking for ways” to provide certain people with access to these booster vaccines “before any potential changes in regulatory decisions on vaccination “.

This news was revealed by The New York Times, who noticed that the consensus to apply another dose increases as the laboratory vaccine Pfizer it is less effective against COVID-19 after six months.

“Pfizer’s ongoing global study of participants in its clinical trials shows that four to six months after the second dose, the vaccine’s effectiveness against symptomatic infection goes from 95% to 84%, according to companyThe article revealed. A week ago, the World Health Organization (WHO) not recommended a third dose of the vaccine against the coronavirus.

“The goal of this vaccine is not to prevent mild or mild, moderate infectious diseases. The goal is to avoid hospitalization to death. At this time, this vaccine has been kept up to date, ”the doctor said. Paul Offit, member of the FDA External Vaccine Advisory Committee.

One of the downsides put on the table is the disbelief that the confirmation that a third dose is needed to strengthen the immune system could generate. “We don’t want people to believe that when they talk about boosters it means the vaccines aren’t working,” the doctor said. Antoine Fauci during a hearing he gave last Tuesday before members of the United States Congress.

“Normally, the FDA would authorize the use of a booster dose, perhaps after a meeting of your external advisory committee. Then the CDC, which has its own advisory board, should officially recommend it, ”Offit said.

2.7% of the population -According to the CDC- has a weakened immune system. This group includes cancer patients, those who have been transplanted or those who have diseases, infections, among others.